Levosimendan for the treatment of acute severe heart failure: a meta-analysis of randomised controlled trials.
about
Inotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndromeLevosimendan: current data, clinical use and future developmentThe Role of Levosimendan in Patients with Decreased Left Ventricular Function Undergoing Cardiac SurgeryAnesthetic Management for Cardiopulmonary Bypass: Update for 2014.An efficacy and mechanism evaluation study of Levosimendan for the Prevention of Acute oRgan Dysfunction in Sepsis (LeoPARDS): protocol for a randomized controlled trial.The effects of levosimendan and glibenclamide on circulatory and metabolic variables in a canine model of acute hypoxiaInotrope use and outcomes among patients hospitalized for heart failure: impact of systolic blood pressure, cardiac index, and etiologyEffects of Levosimendan on Patients with Heart Failure Complicating Acute Coronary Syndrome: A Meta-Analysis of Randomized Controlled Trials.Levosimendan versus dobutamine in critically ill patients: a meta-analysis of randomized controlled trials.Cardiac inotropes: current agents and future directions.Dobutamine for patients with severe heart failure: a systematic review and meta-analysis of randomised controlled trials.The use of levosimendan in children with cancer with severe acute cardiac dysfunction: case series and a review of the literature.Effects of levosimendan for low cardiac output syndrome in critically ill patients: systematic review with meta-analysis and trial sequential analysis.Drug Treatment of Heart Failure in Children: Focus on Recent Recommendations from the ISHLT Guidelines for the Management of Pediatric Heart Failure.Role of PiCCO monitoring for the integrated management of neurogenic pulmonary edema following traumatic brain injury: A case report and literature review.Long-term levosimendan treatment improves systolic function and myocardial relaxation in mice with cardiomyocyte-specific disruption of the Serca2 gene.The inodilator levosimendan as a treatment for acute heart failure in various settings.Levosimendan improves hemodynamic status in critically ill patients with severe aortic stenosis and left ventricular dysfunction: an interventional study.Levosimendan suppresses oxidative injury, apoptotic signaling and mitochondrial degeneration in streptozotocin-induced diabetic cardiomyopathy.
P2860
Q24201225-78D722DD-7B78-4A91-99C4-5F96C00F8B5AQ24629274-10E96335-9690-4770-82A2-44FBFB044EFBQ28075665-469D36B9-B09F-4EA6-ACF3-D0B822FCFCBBQ30457850-2299BDE8-2BC7-4D38-A4C2-5268CF587CC2Q33770902-2F57C454-E0DE-43CE-89AB-9E4DF959CA85Q34680182-84E3A8EB-0814-400C-9110-38CAF84C5D19Q35077700-0333506D-7E7F-422F-87E5-701838C13AFCQ36396523-C6C5EE47-EE8A-435F-9FF0-CCFF62C3DE08Q36832816-7148B80B-20E7-47A8-8FFE-1B48D3F45407Q37851240-76A7FAA6-13EF-4BC7-8812-465F48369F38Q37967364-3F812665-6EDA-4B36-A642-FD3AAE764EDDQ38105336-DCCF64DA-044B-4F25-B630-EE1D1364D46CQ38292123-E3A1BEB1-6148-4271-92C8-9A4A74EB06A6Q38900417-F9A2DAE3-0578-452E-A6DF-A4142DC28B71Q38971428-0E2BC659-E662-420B-84EC-19D3D00F574CQ46728107-D3AB7780-8436-4410-AF41-3EA251B3F386Q47097922-CFBE9E9D-EDE6-42FD-A1E2-7E929EC26ED1Q53511466-0D1C74AC-58A9-42F7-A90C-9CEE1761A7B0Q54257049-928D2F14-CE99-4CDE-BD67-95782FDF37B0
P2860
Levosimendan for the treatment of acute severe heart failure: a meta-analysis of randomised controlled trials.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Levosimendan for the treatment ...... randomised controlled trials.
@en
Levosimendan for the treatment ...... randomised controlled trials.
@nl
type
label
Levosimendan for the treatment ...... randomised controlled trials.
@en
Levosimendan for the treatment ...... randomised controlled trials.
@nl
prefLabel
Levosimendan for the treatment ...... randomised controlled trials.
@en
Levosimendan for the treatment ...... randomised controlled trials.
@nl
P2093
P1476
Levosimendan for the treatment ...... randomised controlled trials.
@en
P2093
Anthony Delaney
Celia Bradford
John McCaffrey
Richard Lee
Sean M Bagshaw
P304
P356
10.1016/J.IJCARD.2008.08.020
P577
2008-09-24T00:00:00Z